NO20011412L - Fremgangsmåter for nedmodulering av immunresponsen til terapeutiske proteiner - Google Patents

Fremgangsmåter for nedmodulering av immunresponsen til terapeutiske proteiner

Info

Publication number
NO20011412L
NO20011412L NO20011412A NO20011412A NO20011412L NO 20011412 L NO20011412 L NO 20011412L NO 20011412 A NO20011412 A NO 20011412A NO 20011412 A NO20011412 A NO 20011412A NO 20011412 L NO20011412 L NO 20011412L
Authority
NO
Norway
Prior art keywords
modulating
methods
immune response
therapeutic proteins
proteins
Prior art date
Application number
NO20011412A
Other languages
English (en)
Norwegian (no)
Other versions
NO20011412D0 (no
Inventor
Jiahua Qian
Leon W Hoyer
Mary Collins
Gary S Gray
Original Assignee
Genetics Inst
American Nat Red Cross
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Inst, American Nat Red Cross filed Critical Genetics Inst
Publication of NO20011412D0 publication Critical patent/NO20011412D0/no
Publication of NO20011412L publication Critical patent/NO20011412L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20011412A 1998-09-21 2001-03-20 Fremgangsmåter for nedmodulering av immunresponsen til terapeutiske proteiner NO20011412L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15817898A 1998-09-21 1998-09-21
PCT/US1999/021991 WO2000016801A1 (en) 1998-09-21 1999-09-21 Methods of downmodulating the immune response to therapeutic proteins

Publications (2)

Publication Number Publication Date
NO20011412D0 NO20011412D0 (no) 2001-03-20
NO20011412L true NO20011412L (no) 2001-05-16

Family

ID=22566971

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20011412A NO20011412L (no) 1998-09-21 2001-03-20 Fremgangsmåter for nedmodulering av immunresponsen til terapeutiske proteiner

Country Status (21)

Country Link
EP (1) EP1115423A1 (zh)
JP (1) JP2002526455A (zh)
KR (1) KR20010085830A (zh)
CN (1) CN1331602A (zh)
AU (1) AU761206B2 (zh)
BR (1) BR9913991A (zh)
CA (1) CA2343916A1 (zh)
CZ (1) CZ20011021A3 (zh)
EA (1) EA005236B1 (zh)
HK (1) HK1039059A1 (zh)
HU (1) HUP0103960A3 (zh)
IL (1) IL142069A0 (zh)
LT (1) LT4920B (zh)
LV (1) LV12768B (zh)
MX (1) MXPA01002898A (zh)
NO (1) NO20011412L (zh)
NZ (1) NZ511034A (zh)
PL (1) PL346796A1 (zh)
SI (1) SI20626A (zh)
WO (1) WO2000016801A1 (zh)
ZA (1) ZA200103156B (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5397703A (en) 1992-07-09 1995-03-14 Cetus Oncology Corporation Method for generation of antibodies to cell surface molecules
AU6173501A (en) * 2000-05-19 2001-12-03 Blood Res Center Methods for diagnosing and treating hemostatic disorders by modulating p-selectin activity
EP1636579A4 (en) * 2003-06-10 2011-10-05 Smiths Detection Inc SENSOR ASSEMBLY
GB201508024D0 (en) * 2015-05-11 2015-06-24 Haemostatix Ltd Haemostatic compositions

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5171569A (en) 1985-03-15 1992-12-15 National Research Development Corporation Factor IX preparations uncontaminated by plasma components or pox virus
AU5772886A (en) 1985-04-12 1986-11-05 Genetics Institute Inc. Novel procoagulant proteins
US5422260A (en) 1986-05-29 1995-06-06 Genetics Institute, Inc. -Legal Affairs Human factor VIII:c muteins
US4994371A (en) 1987-08-28 1991-02-19 Davie Earl W DNA preparation of Christmas factor and use of DNA sequences
FR2657884B1 (fr) 1990-02-05 1994-09-02 Tm Innovation Procede pour la preparation du facteur viii humain et d'analogues du facteur viii.
US5661008A (en) 1991-03-15 1997-08-26 Kabi Pharmacia Ab Recombinant human factor VIII derivatives
ES2123001T5 (es) 1991-06-27 2009-04-16 Bristol-Myers Squibb Company Receptor ctl4a, proteinas de fusion que lo contienen y sus usos.
US5770197A (en) 1991-06-27 1998-06-23 Bristol-Myers Squibb Company Methods for regulating the immune response using B7 binding molecules and IL4-binding molecules
WO1993009804A1 (en) 1991-11-18 1993-05-27 The Scripps Research Institute Serine protease derived-polypeptides and anti-peptide antibodies, systems and therapeutic methods for inhibiting coagulation
US5744446A (en) 1992-04-07 1998-04-28 Emory University Hybrid human/animal factor VIII
US5364771A (en) 1992-04-07 1994-11-15 Emory University Hybrid human/porcine factor VIII
US5663060A (en) 1992-04-07 1997-09-02 Emory University Hybrid human/animal factor VIII
US5621039A (en) 1993-06-08 1997-04-15 Hallahan; Terrence W. Factor IX- polymeric conjugates
AU3161695A (en) * 1994-08-19 1996-03-14 Novo Nordisk A/S A method of treating a patient with a biologically active compound
JPH10507758A (ja) * 1994-10-19 1998-07-28 ジェネティック セラピー，インコーポレイテッド アデノウイルスおよび免疫抑制剤同時反復投与を伴う遺伝子治療
US5714583A (en) 1995-06-07 1998-02-03 Genetics Institute, Inc. Factor IX purification methods
DK0892643T4 (da) * 1996-03-20 2009-12-14 Bristol Myers Squibb Co Fremgangsmåder til inhibering af et immunrespons ved blokering af GP39/CD40- og CTLA4/CD28/B7-banerne og præparater til anvendelse derved
JP2001508450A (ja) * 1997-01-10 2001-06-26 バイオジェン インコーポレイテッド 抗ｃｄ４０ｌ化合物の治療学的投与の方法
NZ502051A (en) * 1997-06-20 2001-04-27 Biogen Inc CD154 blockade therapy for therapeutic protein inhibitor syndrome
US8112896B2 (en) 2009-11-06 2012-02-14 Hexagon Metrology Ab Articulated arm

Also Published As

Publication number Publication date
CN1331602A (zh) 2002-01-16
AU761206B2 (en) 2003-05-29
KR20010085830A (ko) 2001-09-07
HUP0103960A3 (en) 2003-09-29
NO20011412D0 (no) 2001-03-20
LT4920B (lt) 2002-06-25
LV12768B (lv) 2002-06-20
SI20626A (sl) 2002-02-28
WO2000016801A9 (en) 2000-10-26
EA005236B1 (ru) 2004-12-30
HK1039059A1 (zh) 2002-04-12
LV12768A (en) 2001-12-20
AU6057899A (en) 2000-04-10
PL346796A1 (en) 2002-02-25
EA200100385A1 (ru) 2001-10-22
CZ20011021A3 (cs) 2001-10-17
JP2002526455A (ja) 2002-08-20
ZA200103156B (en) 2002-07-18
HUP0103960A2 (hu) 2002-02-28
LT2001045A (en) 2002-01-25
MXPA01002898A (es) 2002-06-04
EP1115423A1 (en) 2001-07-18
CA2343916A1 (en) 2000-03-30
IL142069A0 (en) 2002-03-10
WO2000016801A1 (en) 2000-03-30
BR9913991A (pt) 2001-07-03
NZ511034A (en) 2004-03-26

Similar Documents

Publication Publication Date Title
IS5375A (is) KAY-nýstárlegt ónæmisprótín
NO985464D0 (no) Konsentrert antistoffpreparat
NO20004133L (no) Antistoffer mot human CD40
NO983766D0 (no) FremgangsmÕte til fremstilling av N-acetyl-D-glukosamin
DE69727923D1 (de) Gehhilfe
EE04390B1 (et) Paikne preparaat dermatoloogiliste seisundite raviks
NO995134D0 (no) Forbedrede fremgangsmåter for fremstilling av aktivert protein C
ID24314A (id) Tempat umpan bersekat-sekat
NO20004523D0 (no) Avleveringssystem for Õ modulere immunresponsen
NO960482D0 (no) Skosåle
NO995251D0 (no) FremgangsmÕte for administrering av haloterapi
TR199802394A3 (tr) Proteinleri stabilize etmek için gelistirilmis proses.
DK1109450T3 (da) Mikrokapselpræparater
TR199501501A2 (tr) Sekerlemelerin hazirlanmasi.
NO975563L (no) Anordning til innbyrdes fastholdelse av to gjenstander
NO20010842L (no) Forbindelseselement for sammenkobling av to komponenter
TR199800403A3 (tr) a-Bromo-laktam türevlerinin hazirlanmasi için yöntem.
NO20011412D0 (no) FremgangsmÕter for nedmodulering av immunresponsen til terapeutiske proteiner
DE69823490D1 (de) Antitranspirant präparat
NO996432D0 (no) Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider
FI951155A (fi) Farmaseuttinen valmiste
ID17941A (id) Metode penerapan komposisi pembuat marka jalan
NO951679L (no) Fibronektin-bindende protein, samt fremstilling derav
NO980316D0 (no) Fremgangsmåte for fremstilling av polymerisater av N-vinylkarprolaktam
DE69737080D1 (de) Extraktion des basischen Myelinproteins

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application